China's first FDA-certified thulium laser skin treatment system

Nanjing Bestview Laser S&t Co., Ltd.'s independently developed thulium laser therapy device (Deluxlase) has successfully passed the rigorous review of the U.S. Food and Drug Administration (FDA), earning China's first FDA-certified thulium laser therapy device for dermatology. This milestone not only marks international recognition of Bestview Laser's technological strength, but also signifies a breakthrough for Chinese medical aesthetic laser equipment in the global high-end equipment market.

Source: FDA official website information

The 1927nm wavelength thulium laser is the "golden safety line" for skin treatment. Its high water absorption properties allow it to precisely target the superficial and middle layers of the skin, releasing most of its heat energy into the dermis rather than the epidermis. The scope and depth of thermal damage are significantly lower than those of traditional ablative lasers (such as Er:YAG). This targeted approach allows it to effectively treat pigmented lesions like freckles and age spots while also stimulating collagen regeneration to improve fine lines, achieving the dual advantages of "precision treatment and minimal damage."

As China's first FDA-certified thulium laser therapy device for dermatology, Deluxlase has passed the most stringent international safety and effectiveness reviews, marking a significant shift for China's medical aesthetic laser equipment industry from a laggard to a leader in precision and compliance. Looking ahead, Bestview Laser will continue to cultivate medical laser technology, empowering more people to embrace health and beauty through the power of technology.